Trinity biotech welcomes trinscreen hiv's inclusion in the new kenyan hiv testing algorithm

Dublin, ireland, march 22, 2023 (globe newswire) -- trinity biotech plc (nasdaq: trib) (the “company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today welcomed the announcement by the kenyan ministry of health of the adoption of a new hiv rapid testing algorithm. this new algorithm establishes trinity biotech's trinscreen hiv as the screening test (a1 = screen test under world health organisation (“who”) guidelines).
TRIB Ratings Summary
TRIB Quant Ranking